Publicaciones (813) Publicaciones en las que ha participado algún/a investigador/a

2014

  1. 18F-FDG PET-CT imaging in the neoadjuvant setting for stages II-III breast cancer: Association of loco-regional SUVmax with classical prognostic factors

    Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 58, Núm. 1, pp. 66-73

  2. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism

    European Heart Journal, Vol. 35, Núm. 43, pp. 3033-3080

  3. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: The task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)

    European Heart Journal, Vol. 35, Núm. 39, pp. 2733-2779

  4. 2014 ESC guidelines on the diagnosis and treatment of aortic diseases

    European Heart Journal, Vol. 35, Núm. 41, pp. 2873-2926

  5. 2014 ESC/EACTS Guidelines on myocardial revascularization

    European Journal of Cardio-thoracic Surgery, Vol. 46, Núm. 4, pp. 517-592

  6. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

    European Heart Journal, Vol. 35, Núm. 37, pp. 2541-2619

  7. 2014 ESC/ESA Guidelines on non-cardiac surgery: Cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: Cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)

    European Heart Journal, Vol. 35, Núm. 35, pp. 2383-2431

  8. 2nd ESMO Consensus Conference on Lung Cancer: Non-small-cell lung cancer first-line/second and further lines in advanced disease

    Annals of Oncology, Vol. 25, Núm. 8, pp. 1475-1484

  9. 2nd ESMO consensus conference on lung cancer: Early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

    Annals of Oncology, Vol. 25, Núm. 8, pp. 1462-1474

  10. A critical review of HER2-positive gastric cancer evaluation and treatment: From trastuzumab, and beyond

    Cancer Letters, Vol. 351, Núm. 1, pp. 30-40

  11. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility

    Arthritis Research and Therapy, Vol. 16, Núm. 1

  12. A histologic scoring system for prognosis of patients with alcoholic hepatitis

    Gastroenterology, Vol. 146, Núm. 5

  13. A low-cost, sustainable, second generation system for surveillance of people living with HIV in Spain: 10-year trends in behavioural and clinical indicators, 2002 to 2011

    Eurosurveillance, Vol. 19, Núm. 20

  14. A nation-wide study of prevalence and risk factors for fecal impaction in nursing homes

    PLoS ONE, Vol. 9, Núm. 8

  15. A new biocompatible and antibacterial phosphate free glass-ceramic for medical applications

    Scientific Reports, Vol. 4

  16. A new case of successful outcome of pregnancy in a carrier of homozygous type II (L99F) antithrombin deficiency

    Blood Coagulation and Fibrinolysis, Vol. 25, Núm. 1, pp. 74-76

  17. A novel antibody against human factor B that blocks formation of the C3bB proconvertase and inhibits complement activation in disease models

    Journal of Immunology, Vol. 193, Núm. 11, pp. 5567-5575

  18. A novel cardiovascular presentation of Alport Syndrome: Spontaneous coronary artery dissection

    International Journal of Cardiology, Vol. 177, Núm. 3, pp. e133-e134

  19. A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro

    American Journal of Hematology, Vol. 89, Núm. 7, pp. 689-694

  20. A polypill strategy to improve adherence

    Journal of the American College of Cardiology, Vol. 64, Núm. 20, pp. 2071-2082